Pay in 4 interest-free payments of $7.39 Learn more
Ships within 48 hours · Estimated delivery Aug 15 - Aug 20
Because the list price cut does not guarantee lower net costs for employers, it is unlikely to materially expand coverage of GLP-1 drugs for obesity
and its affiliates disclaim any warranty or liability relating to this information or the use thereof
UK Clinical Evidence Mounjaro (tirzepatide) is a prescription medicine licensed in the UK for type 2 diabetes and weight management in adults with obesity or overweight with weight-related conditions
When used with insulin or insulin secretagogues in patients with diabetes, there may be an increased risk of hypoglycemia, requiring dose adjustments of these medications
Reconstitution Quick Reference Math: 10,000 mcg / 2 mL = 5,000 mcg/mL
For patients whose commercial insurance plans exclude weight loss coveragewhich is estimated to be over 75% of employer-sponsored plansthe drug is financially out of reach
US$ 23.79
US$ 25.39
US$ 25.18
